Related Experiment Videos
Thrombolytic therapy for mitral valve thrombosis
1Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan ROC.
Summary
Prosthetic heart valve thrombosis (PHVT) can be effectively treated with thrombolytic therapy, offering an alternative to surgery. This approach rapidly improved patient symptoms and valve function with minimal complications.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Thrombotic Disorders
Background:
- Prosthetic heart valve thrombosis (PHVT) is a serious complication, typically managed with surgery.
- Early diagnosis and intervention are crucial for favorable outcomes in PHVT.
Observation:
- A 44-year-old male presented with pulmonary edema and muffled prosthetic valve sounds, indicative of PHVT.
- Echocardiography revealed severe mitral stenosis and limited valve motility.
Findings:
- Intravenous thrombolytic therapy with recombinant tissue plasminogen activator, followed by heparinization, rapidly resolved obstruction and improved symptoms.
- The patient experienced a transient ischemic attack but had no lasting neurological deficits.
Implications:
- Thrombolytic therapy may be a viable alternative to surgery for selected PHVT patients.
- This case highlights the potential efficacy and safety of non-surgical management for PHVT.
- Further research into thrombolytic therapy for PHVT is warranted.